枸橼酸喷托维林结构式
|
常用名 | 枸橼酸喷托维林 | 英文名 | Pentoxyverine Citrate |
---|---|---|---|---|
CAS号 | 23142-01-0 | 分子量 | 525.589 | |
密度 | N/A | 沸点 | 435.5ºC at 760mmHg | |
分子式 | C26H39NO10 | 熔点 | 84-86?C | |
MSDS | 中文版 美版 | 闪点 | 217.2ºC | |
符号 |
GHS07 |
信号词 | Warning |
枸橼酸喷托维林用途Carbetapentane柠檬酸盐对咳嗽中枢有选择性抑制作用, 有轻度的阿托品样作用和局麻作用, |
中文名 | 托可拉斯 |
---|---|
英文名 | carbetapentane citrate |
中文别名 | 柠檬酸喷托维林 | 枸橼酸喷托维林 | 妥克拉司 | 咳必清 |
英文别名 | 更多 |
沸点 | 435.5ºC at 760mmHg |
---|---|
熔点 | 84-86?C |
分子式 | C26H39NO10 |
分子量 | 525.589 |
闪点 | 217.2ºC |
精确质量 | 525.257385 |
PSA | 170.90000 |
LogP | 2.15150 |
外观性状 | 白色至灰白色固体 |
储存条件 | 放入紧密的贮藏器内,储存在阴凉,干燥的地方 |
稳定性 | 常温常压下稳定 |
水溶解性 | H2O: soluble |
分子结构 | |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:4 3.氢键受体数量:11 4.可旋转化学键数量:16 5.互变异构体数量:无 6.拓扑分子极性表面积171 7.重原子数量:37 8.表面电荷:0 9.复杂度:583 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
更多 | 1.性状:未确定 2.密度(g/mL,25/4℃):未确定 3.相对蒸汽密度(g/mL,空气=1):未确定 4.熔点(ºC):未确定 5.沸点(ºC,常压):未确定 6.沸点(ºC,5.2kPa):未确定 7.折射率:未确定 8.闪点(ºC):未确定 9.比旋光度(º):未确定 10.自燃点或引燃温度(ºC):未确定 11.蒸气压(kPa,25ºC):未确定 12.饱和蒸气压(kPa,60ºC):未确定 13.燃烧热(KJ/mol):未确定 14.临界温度(ºC):未确定 15.临界压力(KPa):未确定 16.油水(辛醇/水)分配系数的对数值:未确定 17.爆炸上限(%,V/V):未确定 18.爆炸下限(%,V/V):未确定 19.溶解性:溶于水 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302-H312-H315-H319-H332-H335 |
警示性声明 | P261-P280-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn:Harmful; |
风险声明 (欧洲) | R20/21/22;R36/37/38 |
安全声明 (欧洲) | S26-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | GY3500000 |
海关编码 | 2922509090 |
海关编码 | 2922509090 |
---|---|
中文概述 | 2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:AB. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
监管条件 | A.入境货物通关单 B.出境货物通关单 |
检验检疫 | R.进口食品卫生监督检验 S.出口食品卫生监督检验 |
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices.
Brain Res. 564 , 341, (1991) The non-opioid antitussive drugs, dextromethorphan, caramiphen and carbetapentane, are also anticonvulsant. The effects of these antitussives on potassium-stimulated release of endogenous amino acids ... |
|
Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway.
Br. J. Pharmacol. 125 , 510-516, (1998) 1. Electrical field stimulation (EFS) of guinea-pig isolated main bronchi induced a non-adrenergic non-cholinergic (NANC) contractile response. Nociceptin (0.01-1 microm) significantly inhibited the c... |
|
Effects of sigma ligands on the nociceptin/orphanin FQ receptor co-expressed with the G-protein-activated K+ channel in Xenopus oocytes.
Br. J. Pharmacol. 120 , 986-987, (1997) Taking advantage of the functional coupling of the nociceptin/orphanin FQ receptor with the G-protein-activated inwardly rectifying K+ (GIRK) channel, we investigated the effects of various sigma liga... |
Takabetan |
PENCAL |
carbetapentonecitrate |
Pentoxyverine Citrate |
Cyclopentanecarboxylic acid,1-phenyl-,2-[2-(diethylamino)ethoxy]ethyl ester |
Astomatop |
PENTOXIVERINE CITRATE |
loucarbate |
2-[2-(Diethylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate 2-hydroxy-1,2,3-propanetricarboxylate (1:1) |
2-[2-(Diethylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate 2-hydroxypropane-1,2,3-tricarboxylate (1:1) |
Carbetapentan-citrat |
toclase |
Gai-Less |
1-Phenylcyclopentanecarboxylic Acid 2-(2-(Diethylamino)ethoxy)ethyl Ester Citrate (1:1) |
Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt) |
EINECS 245-449-5 |
CARETAPENTANE CITRATE |
Carbetapentane citrate salt |
1-Phenylcyclopentanecarboxylic acid 2-(2-diethylaminoethoxy)ethyl ester citrate salt |
Atomin S |
MFCD00055697 |
2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid |
Fustpentane |
Calnathal |
Carbetapentane (citrate) |